deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT04322682

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19)

Sponsor: Bill and Melinda Gates Foundation

Conditions Corona Virus Infection
Interventions Colchicine Placebo oral tablet
Updated 17 times since 2020 Last updated: Nov 19, 2024 Started: Mar 23, 2020 Primary completion: Jan 21, 2021 Completion: Jan 21, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to several considerations (logistical, human and budgetary), the study was stopped early.

Other terminated trials from Bill and Melinda Gates Foundation

See all terminations from Bill and Melinda Gates Foundation

Other Corona Virus Infection trials with similar outcome

Browse all Corona Virus Infection trials

This PHASE3 trial investigates Corona Virus Infection and is currently terminated or withdrawn. Bill and Melinda Gates Foundation leads this study, which shows 17 recorded versions since 2020 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Sep 2020 · 2 months · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Jan 2025 · 31 days · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Feb 2025 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jan 2025 — Feb 2025 [monthly]

    Terminated PHASE3

  4. Dec 2024 — Jan 2025 [monthly]

    Terminated PHASE3

  5. Sep 2024 — Dec 2024 [monthly]

    Terminated PHASE3

▶ Show 12 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  2. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  3. Oct 2021 — Dec 2021 [monthly]

    Terminated PHASE3

    Status: Completed → Terminated

  4. Feb 2021 — Oct 2021 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  5. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

  6. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  7. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE3

  8. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE3

  9. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE3

  10. Jul 2020 — Sep 2020 [monthly]

    Recruiting PHASE3

  11. May 2020 — Jul 2020 [monthly]

    Recruiting PHASE3

  12. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE3

    First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bill and Melinda Gates Foundation
  • Dacima Software Inc.
  • Montreal Heart Institute
  • National Heart, Lung, and Blood Institute (NHLBI)
  • The Government of Quebec
Data source: Montreal Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bakersfield, United States , Beverly Hills, United States , Bragança Paulista, Brazil , Cape Town, South Africa , Chapel Hill, United States , Chaïdári, Greece , Cruz Alta, Brazil , Dallas, United States , Downey, United States , Houston, United States and 16 more locations